In the WHO guidelines (http://www.who.int/biologicals/publications/trs/ areas/vaccines/pneumo/en/index.html) the primary threshold for such trials is the proportion of subjects with antibody concentration of 0.35 mg/mL for all serotypes when measured via the WHO non-22F ELISA.